Get real time updates directly on you device, subscribe now.
IMARC Group’s report titled “Cytokine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The global cytokine market share, size, trends, growth, analysis and forecasts. The global cytokine market size reached US$ 83.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 130.5 Billion by 2028, exhibiting a growth rate (CAGR) of 7.66% during 2023-2028.
Cytokines are small proteins paramount in cell signaling and communication and help regulate immune responses and inflammation. They are produced by a wide array of cells, which include macrophages, B lymphocytes, T lymphocytes, mast cells, endothelial cells, and fibroblasts. They exhibit a high level of pleiotropy and redundancy, meaning that their actions can overlap, and multiple cytokines can elicit similar responses. They aid in promoting cell growth and differentiation and coordinating the cellular response to various stimuli, such as infection and injury. Besides this, as they offer potential targets for the development of treatments for various diseases, the demand for cytokines is increasing globally.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/cytokine-market/requestsample
Cytokine Market Trends and Drivers:
The rising prevalence of several chronic diseases is leading to an increasing demand for effective treatments and therapies. Additionally, the increasing use of cytokines in the pharmaceutical industry, on account of their immune responses and inflammation, is favoring market growth. Apart from this, the technological advancement in bio-production and purification methods, coupled with the development of more efficient and cost-effective processes for cytokine production, is continually enhancing the accessibility and affordability of cytokine-based therapies. Furthermore, the growing focus on research and development (R&D) in biotechnology and pharmaceuticals is offering a favorable market outlook. Moreover, government policies promoting biomedical research, along with funding support for innovative projects, are driving forward the development and application of cytokines in various therapeutic areas.
Competitive Landscape with Key Player:
- AbbVie Inc.
- Abcam plc
- Amgen Inc.
- Applied Biological Materials Inc. (abm)
- Bio-Techne Corporation
- F. Hoffmann-La Roche AG
- GenScript Biotech Corporation
- Randox Laboratories Ltd.
- Thermo Fisher Scientific Inc.
- UCB S.A.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Cytokine Type:
- Tumor Necrosis Factor-TNF
- Interleukins-Il
- Interferons-IFN
- Epidermal Growth Factor-EGF
- Others
Breakup by Therapeutic Application:
- Cancer
- Asthma and Airway Inflammation
- Arthritis
- Others
Breakup by End User:
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Academic and Research Institutes
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800\
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal
Comments are closed.